Sun Pharmaceutical Industries Ltd. closed 14.82% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 14.40% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) is set to release its Q3 2025 earnings on Jan 31, 2025. The consensus estimate for Q3 2025 revenue is $134.22 billion, and the earnings are ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sun Pharma announced a 15 per cent year-on-year (YoY) increase, reaching ₹2,903 crore for the quarter ending December 2024. The company also recorded an exceptional item of ₹316 crore during ...

HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical (SUN.NS), opens new tab, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong ...

12 May, 2015 16 Mar, 2016 5:116 244 For every 116 shares held; holder is entitled to apply 5 rights shares at a premium of RS 244 14 Jul, 2011 23 Aug, 2012 1:7 66 For every 7 shares held; holder ...

Leqselvi is now FDA approved for treating severe alopecia areata. Sun Pharma added the oral drug to its pipeline via the $576 million acquisition of Concert Pharmaceuticals last year. Sun ...

Considering today's low, the Nifty pharma index has fallen over 7 per cent in the last three days. On a monthly scale, the index has declined nearly 12 per cent against a 3 per cent fall in the ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...